Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 447

1.

Author's reply to: Implementation and organization of cancer screening in France.

Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, Segnan N, Tomatis M, Soerjomataram I, Primic Žakelj M, Dillner J, Elfström KM, Lönnberg S, Sankaranaryanan R.

Int J Cancer. 2018 Jun 26. doi: 10.1002/ijc.31629. [Epub ahead of print] No abstract available.

PMID:
29943811
2.

ICTV Virus Taxonomy Profile: Papillomaviridae.

Van Doorslaer K, Chen Z, Bernard HU, Chan PKS, DeSalle R, Dillner J, Forslund O, Haga T, McBride AA, Villa LL, Burk RD, Ictv Report Consortium.

J Gen Virol. 2018 Jun 21. doi: 10.1099/jgv.0.001105. [Epub ahead of print]

PMID:
29927370
3.

[Cervical cancer has increased in Sweden in women who had a normal cell sample].

Dillner J, Sparén P, Andrae B, Strander B.

Lakartidningen. 2018 Jun 5;115. pii: E9FD. Swedish.

4.

Human Papillomavirus Serology Among Women Living With HIV: Type-Specific Seroprevalence, Seroconversion, and Risk of Cervical Reinfection.

Kelly H, Faust H, Chikandiwa A, Ngou J, Weiss HA, Segondy M, Dillner J, Delany-Moretlwe S, Mayaud P.

J Infect Dis. 2018 May 30. doi: 10.1093/infdis/jiy252. [Epub ahead of print]

PMID:
29850832
5.

Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomised trial (III).

Lehtinen M, Luostarinen T, Vänskä S, Söderlund-Strand A, Eriksson T, Natunen K, Apter D, Baussano I, Harjula K, Hokkanen M, Kuortti M, Palmroth J, Petäjä T, Pukkala E, Rekonen S, Siitari-Mattila M, Surcel HM, Tuomivaara L, Paavonen J, Nieminen P, Dillner J, Dubin G, Garnett G.

Int J Cancer. 2018 May 30. doi: 10.1002/ijc.31618. [Epub ahead of print]

PMID:
29845626
6.

Determinants of the presence of human papillomaviruses in the anal canal of Russian men.

Smelov V, Elfström KM, Eklund C, Sokolova O, Dillner J.

J Med Virol. 2018 May 24. doi: 10.1002/jmv.25234. [Epub ahead of print]

PMID:
29797586
7.

Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs.

Dillner J, Nygård M, Munk C, Hortlund M, Hansen BT, Lagheden C, Liaw KL, Kjaer SK.

Vaccine. 2018 Jun 18;36(26):3820-3829. doi: 10.1016/j.vaccine.2018.05.019. Epub 2018 May 31.

PMID:
29778519
8.

Viremia preceding multiple sclerosis: Two nested case-control studies.

Hultin E, Mühr LSA, Bzhalava Z, Hortlund M, Lagheden C, Sundström P, Dillner J.

Virology. 2018 Jul;520:21-29. doi: 10.1016/j.virol.2018.04.006. Epub 2018 May 14.

PMID:
29772404
9.

Suppressive antiretroviral therapy associates with effective treatment of high-grade cervical intraepithelial neoplasia.

Carlander C, Wagner P, van Beirs A, Yilmaz A, Elfgren K, Dillner J, Sönnerborg A, Sparén P.

AIDS. 2018 Jul 17;32(11):1475-1484. doi: 10.1097/QAD.0000000000001853.

PMID:
29746299
10.

Estimating effectiveness of HPV vaccination against HPV infection from post-vaccination data in the absence of baseline data.

Vänskä S, Söderlund-Strand A, Uhnoo I, Lehtinen M, Dillner J.

Vaccine. 2018 May 31;36(23):3239-3246. doi: 10.1016/j.vaccine.2018.04.073. Epub 2018 Apr 30.

PMID:
29716776
11.

Towards quality and order in human papillomavirus research.

Mühr LSA, Eklund C, Dillner J.

Virology. 2018 Jun;519:74-76. doi: 10.1016/j.virol.2018.04.003. Epub 2018 Apr 18.

PMID:
29679790
12.

Invitation strategies and coverage in the population-based cancer screening programmes in the European Union.

Vale DB, Anttila A, Ponti A, Senore C, Sankaranaryanan R, Ronco G, Segnan N, Tomatis M, Žakelj MP, Elfström KM, Lönnberg S, Dillner J, Basu P.

Eur J Cancer Prev. 2018 Mar 21. doi: 10.1097/CEJ.0000000000000426. [Epub ahead of print]

PMID:
29570103
13.

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer.

Lagheden C, Eklund C, Lamin H, Kleppe SN, Lei J, Elfström KM, Sundström K, Andrae B, Sparén P, Dillner J.

Br J Cancer. 2018 May;118(10):1377-1381. doi: 10.1038/s41416-018-0053-6. Epub 2018 Mar 21.

PMID:
29559733
14.

Seroprevalences of Antibodies to 11 Human Papillomavirus (HPV) Types Mark Cumulative HPV Exposure.

Artemchuk H, Triglav T, Oštrbenk A, Poljak M, Dillner J, Faust H.

J Infect Dis. 2018 Jul 2;218(3):398-405. doi: 10.1093/infdis/jiy107.

PMID:
29529245
15.

Author's reply to: Cancer screening policy in Hungary.

Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, Segnan N, Tomatis M, Soerjomataram I, Primic Žakelj M, Dillner J, Elfström KM, Lönnberg S, Sankaranarayanan R.

Int J Cancer. 2018 Aug 15;143(4):1005. doi: 10.1002/ijc.31371. Epub 2018 Mar 30. No abstract available.

PMID:
29524204
16.

Replik till Erik Wilander: - Okänd orsak till ökning av cervixcancer.

Dillner J, Andrae B, Strander B, Sparén P.

Lakartidningen. 2018 Feb 26;115. pii: E3HS. Swedish. No abstract available.

PMID:
29485668
Free Article
17.

Epigenome-based cancer risk prediction: rationale, opportunities and challenges.

Widschwendter M, Jones A, Evans I, Reisel D, Dillner J, Sundström K, Steyerberg EW, Vergouwe Y, Wegwarth O, Rebitschek FG, Siebert U, Sroczynski G, de Beaufort ID, Bolt I, Cibula D, Zikan M, Bjørge L, Colombo N, Harbeck N, Dudbridge F, Tasse AM, Knoppers BM, Joly Y, Teschendorff AE, Pashayan N; FORECEE (4C) Consortium.

Nat Rev Clin Oncol. 2018 May;15(5):292-309. doi: 10.1038/nrclinonc.2018.30. Epub 2018 Feb 27. Review.

PMID:
29485132
18.

Continuing global improvement in human papillomavirus DNA genotyping services: The 2013 and 2014 HPV LabNet international proficiency studies.

Eklund C, Forslund O, Wallin KL, Dillner J.

J Clin Virol. 2018 Apr;101:74-85. doi: 10.1016/j.jcv.2018.01.016. Epub 2018 Feb 10.

PMID:
29433017
19.

Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II).

Gray P, Palmroth J, Luostarinen T, Apter D, Dubin G, Garnett G, Eriksson T, Natunen K, Merikukka M, Pimenoff V, Söderlund-Strand A, Vänskä S, Paavonen J, Pukkala E, Dillner J, Lehtinen M.

Int J Cancer. 2018 Jun 15;142(12):2491-2500. doi: 10.1002/ijc.31281. Epub 2018 Feb 12.

PMID:
29377141
20.

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development.

Pinto LA, Dillner J, Beddows S, Unger ER.

Vaccine. 2018 Jan 17. pii: S0264-410X(18)30020-3. doi: 10.1016/j.vaccine.2017.11.089. [Epub ahead of print]

PMID:
29361344
21.

Extension of the viral ecology in humans using viral profile hidden Markov models.

Bzhalava Z, Hultin E, Dillner J.

PLoS One. 2018 Jan 19;13(1):e0190938. doi: 10.1371/journal.pone.0190938. eCollection 2018.

22.

Vaccination protects against invasive HPV-associated cancers.

Luostarinen T, Apter D, Dillner J, Eriksson T, Harjula K, Natunen K, Paavonen J, Pukkala E, Lehtinen M.

Int J Cancer. 2018 May 15;142(10):2186-2187. doi: 10.1002/ijc.31231. Epub 2018 Jan 4. No abstract available.

PMID:
29280138
23.

Risk of high-grade lesions after atypical glandular cells in cervical screening: a population-based cohort study.

Norman I, Hjerpe A, Dillner J.

BMJ Open. 2017 Dec 14;7(12):e017070. doi: 10.1136/bmjopen-2017-017070.

24.

Chlamydia trachomatis Strain Types Have Diversified Regionally and Globally with Evidence for Recombination across Geographic Divides.

Smelov V, Vrbanac A, van Ess EF, Noz MP, Wan R, Eklund C, Morgan T, Shrier LA, Sanders B, Dillner J, de Vries HJC, Morre SA, Dean D.

Front Microbiol. 2017 Nov 13;8:2195. doi: 10.3389/fmicb.2017.02195. eCollection 2017.

25.

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders.

Lam JUH, Elfström KM, Ejegod DM, Pedersen H, Rygaard C, Rebolj M, Lynge E, Juul KE, Kjær SK, Dillner J, Bonde J.

Br J Cancer. 2018 Jan;118(1):138-144. doi: 10.1038/bjc.2017.371. Epub 2017 Nov 14.

26.

ViraPipe: scalable parallel pipeline for viral metagenome analysis from next generation sequencing reads.

Maarala AI, Bzhalava Z, Dillner J, Heljanko K, Bzhalava D.

Bioinformatics. 2018 Mar 15;34(6):928-935. doi: 10.1093/bioinformatics/btx702.

PMID:
29106455
27.

Cancer Registry follow-up for 17 million person-years of a nationwide maternity cohort.

Lehtinen M, Surcel HM, Natunen K, Pukkala E, Dillner J.

Cancer Med. 2017 Dec;6(12):3060-3064. doi: 10.1002/cam4.1222. Epub 2017 Oct 25.

28.

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.

Wang J, Andrae B, Sundström K, Ploner A, Ström P, Elfström KM, Dillner J, Sparén P.

PLoS Med. 2017 Oct 24;14(10):e1002414. doi: 10.1371/journal.pmed.1002414. eCollection 2017 Oct.

29.

Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).

Lehtinen M, Söderlund-Strand A, Vänskä S, Luostarinen T, Eriksson T, Natunen K, Apter D, Baussano I, Harjula K, Hokkanen M, Kuortti M, Palmroth J, Petäjä T, Pukkala E, Rekonen S, Siitari-Mattila M, Surcel HM, Tuomivaara L, Paavonen J, Dillner J, Dubin G, Garnett G.

Int J Cancer. 2018 Mar 1;142(5):949-958. doi: 10.1002/ijc.31119. Epub 2017 Nov 9.

PMID:
29055031
30.

A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries.

Kjaer SK, Nygård M, Dillner J, Brooke Marshall J, Radley D, Li M, Munk C, Hansen BT, Sigurdardottir LG, Hortlund M, Tryggvadottir L, Joshi A, Das R, Saah AJ.

Clin Infect Dis. 2018 Jan 18;66(3):339-345. doi: 10.1093/cid/cix797.

PMID:
29029053
31.

Human Papillomavirus (HPV) Prevalence in Male Adolescents 4 Years After HPV-16/18 Vaccination.

Lehtinen T, Söderlund-Strand A, Petäjä T, Eriksson T, Jokiranta S, Natunen K, Dillner J, Lehtinen M.

J Infect Dis. 2017 Nov 15;216(8):966-968. doi: 10.1093/infdis/jix415.

PMID:
28968844
32.

Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.

Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, Segnan N, Tomatis M, Soerjomataram I, Primic Žakelj M, Dillner J, Elfström KM, Lönnberg S, Sankaranarayanan R.

Int J Cancer. 2018 Jan 1;142(1):44-56. doi: 10.1002/ijc.31043. Epub 2017 Oct 10. Erratum in: Int J Cancer. 2018 Jul 1;143(1):E1.

PMID:
28940326
33.

Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study.

Baussano I, Lazzarato F, Ronco G, Lehtinen M, Dillner J, Franceschi S.

J Infect Dis. 2017 Aug 1;216(3):336-344. doi: 10.1093/infdis/jix299.

34.

Viruses in cancers among the immunosuppressed.

Arroyo Mühr LS, Bzhalava Z, Hortlund M, Lagheden C, Nordqvist Kleppe S, Bzhalava D, Hultin E, Dillner J.

Int J Cancer. 2017 Dec 15;141(12):2498-2504. doi: 10.1002/ijc.31017. Epub 2017 Sep 13.

PMID:
28840939
35.

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.

Lehtinen M, Lagheden C, Luostarinen T, Eriksson T, Apter D, Harjula K, Kuortti M, Natunen K, Palmroth J, Petäjä T, Pukkala E, Siitari-Mattila M, Struyf F, Nieminen P, Paavonen J, Dubin G, Dillner J.

BMJ Open. 2017 Aug 18;7(8):e015867. doi: 10.1136/bmjopen-2017-015867.

36.

Erratum to: Development of a Unifying Target and Consensus Indicators for Global Surgical Systems Strengthening: Proposed by the Global Alliance for Surgery, Obstetric, Trauma, and Anaesthesia Care (The G4 Alliance).

Haider A, Scott JW, Gause CD, Meheš M, Hsiung G, Prelvukaj A, Yanocha D, Baumann LM, Ahmed F, Ahmed N, Anderson S, Angate H, Arfaa L, Asbun H, Ashengo T, Asuman K, Ayala R, Bickler S, Billingsley S, Bird P, Botman M, Butler M, Buyske J, Capozzi A, Casey K, Clayton C, Cobey J, Cotton M, Deckelbaum D, Derbew M, deVries C, Dillner J, Downham M, Draisin N, Echinard D, Elneil S, ElSayed A, Estelle A, Finley A, Frenkel E, Frykman PK, Gheorghe F, Gore-Booth J, Henker R, Henry J, Henry O, Hoemeke L, Hoffman D, Ibanga I, Jackson EV Jr, Jani P, Johnson W, Jones A, Kassem Z, Kisembo A, Kocan A, Krishnaswami S, Lane R, Latif A, Levy B, Linos D, Linz P, Listwa LA, Magee D, Makasa E, Marin ML, Martin C, McQueen K, Morgan J, Moser R, Neighbor R, Novick WM, Ogendo S, Omigbodun A, Onajin-Obembe B, Parsan N, Philip BK, Price R, Rasheed S, Ratel M, Reynolds C, Roser SM, Rowles J, Samad L, Sampson J, Sanghvi H, Sellers ML, Sigalet D, Steffes BC, Stieber E, Swaroop M, Tarpley J, Varghese A, Varughese J, Wagner R, Warf B, Wetzig N, Williamson S, Wood J, Zeidan A, Zirkle L, Allen B, Abdullah F.

World J Surg. 2017 Oct;41(10):2423-2425. doi: 10.1007/s00268-017-4067-7. No abstract available.

PMID:
28642965
37.

Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56-60.

Lamin H, Eklund C, Elfström KM, Carlsten-Thor A, Hortlund M, Elfgren K, Törnberg S, Dillner J.

BMJ Open. 2017 May 30;7(5):e014788. doi: 10.1136/bmjopen-2016-014788.

38.

Development of a Unifying Target and Consensus Indicators for Global Surgical Systems Strengthening: Proposed by the Global Alliance for Surgery, Obstetric, Trauma, and Anaesthesia Care (The G4 Alliance).

Haider A, Scott JW, Gause CD, Meheš M, Hsiung G, Prelvukaj A, Yanocha D, Baumann LM, Ahmed F, Ahmed N, Anderson S, Angate H, Arfaa L, Asbun H, Ashengo T, Asuman K, Ayala R, Bickler S, Billingsley S, Bird P, Botman M, Butler M, Buyske J, Capozzi A, Casey K, Clayton C, Cobey J, Cotton M, Deckelbaum D, Derbew M, deVries C, Dillner J, Downham M, Draisin N, Echinard D, Elneil S, ElSayed A, Estelle A, Finley A, Frenkel E, Frykman PK, Gheorghe F, Gore-Booth J, Henker R, Henry J, Henry O, Hoemeke L, Hoffman D, Ibanga I, Jackson EV Jr, Jani P, Johnson W, Jones A, Kassem Z, Kisembo A, Kocan A, Krishnaswami S, Lane R, Latif A, Levy B, Linos D, Linz P, Listwa LA, Magee D, Makasa E, Marin ML, Martin C, McQueen K, Morgan J, Moser R, Neighbor R, Novick WM, Ogendo S, Omigbodun A, Onajin-Obembe B, Parsan N, Philip BK, Price R, Rasheed S, Ratel M, Reynolds C, Roser SM, Rowles J, Samad L, Sampson J, Sanghvi H, Sellers ML, Sigalet D, Steffes BC, Stieber E, Swaroop M, Tarpley J, Varghese A, Varughese J, Wagner R, Warf B, Wetzig N, Williamson S, Wood J, Zeidan A, Zirkle L, Allen B, Abdullah F.

World J Surg. 2017 Oct;41(10):2426-2434. doi: 10.1007/s00268-017-4028-1. Review. Erratum in: World J Surg. 2017 Jun 22;:.

39.

Risk stratification in cervical cancer screening by complete screening history: Applying bioinformatics to a general screening population.

Baltzer N, Sundström K, Nygård JF, Dillner J, Komorowski J.

Int J Cancer. 2017 Jul 1;141(1):200-209. doi: 10.1002/ijc.30725. Epub 2017 Apr 24.

40.

Effect of naturally acquired type-specific serum antibodies against human papillomavirus type 16 infection.

Triglav T, Artemchuk H, Oštrbenk A, Elfström KM, Faust H, Poljak M, Dillner J.

J Clin Virol. 2017 May;90:64-69. doi: 10.1016/j.jcv.2017.03.002. Epub 2017 Mar 6.

PMID:
28363164
41.

Viruses in case series of tumors: Consistent presence in different cancers in the same subject.

Arroyo Mühr LS, Hortlund M, Bzhalava Z, Nordqvist Kleppe S, Bzhalava D, Hultin E, Dillner J.

PLoS One. 2017 Mar 3;12(3):e0172308. doi: 10.1371/journal.pone.0172308. eCollection 2017.

42.

Cancer risks after solid organ transplantation and after long-term dialysis.

Hortlund M, Arroyo Mühr LS, Storm H, Engholm G, Dillner J, Bzhalava D.

Int J Cancer. 2017 Mar 1;140(5):1091-1101. doi: 10.1002/ijc.30531.

43.

Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial.

Elfgren K, Elfström KM, Naucler P, Arnheim-Dahlström L, Dillner J.

Am J Obstet Gynecol. 2017 Mar;216(3):264.e1-264.e7. doi: 10.1016/j.ajog.2016.10.042. Epub 2016 Nov 5.

PMID:
27825977
44.

Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.

Sundström K, Lu D, Elfström KM, Wang J, Andrae B, Dillner J, Sparén P.

Am J Obstet Gynecol. 2017 Jan;216(1):48.e1-48.e15. doi: 10.1016/j.ajog.2016.07.042. Epub 2016 Jul 25.

45.

Corrigendum: Detection of DNA viruses in prostate cancer.

Smelov V, Bzhalava D, Mühr LS, Eklund C, Komyakov B, Gorelov A, Dillner J, Hultin E.

Sci Rep. 2016 May 31;6:26267. doi: 10.1038/srep26267. No abstract available.

46.

Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control Study.

Smelov V, Gheit T, Sundström K, Ploner A, McKay-Chopin S, Eklund C, Tommasino M, Dillner J.

PLoS One. 2016 May 26;11(5):e0156215. doi: 10.1371/journal.pone.0156215. eCollection 2016.

47.

Validation of a standardized extraction method for formalin-fixed paraffin-embedded tissue samples.

Lagheden C, Eklund C, Kleppe SN, Unger ER, Dillner J, Sundström K.

J Clin Virol. 2016 Jul;80:36-9. doi: 10.1016/j.jcv.2016.04.016. Epub 2016 Apr 27.

48.

Detection of DNA viruses in prostate cancer.

Smelov V, Bzhalava D, Arroyo Mühr LS, Eklund C, Komyakov B, Gorelov A, Dillner J, Hultin E.

Sci Rep. 2016 Apr 28;6:25235. doi: 10.1038/srep25235. Erratum in: Sci Rep. 2016 May 31;6:26267.

49.

Registry-based assessment of the status of cervical screening in Sweden.

Elfström KM, Sparén P, Olausson P, Almstedt P, Strander B, Dillner J.

J Med Screen. 2016 Dec;23(4):217-226. Epub 2016 Apr 11.

PMID:
27068429
50.

Cohort Profile: The Janus Serum Bank Cohort in Norway.

Langseth H, Gislefoss RE, Martinsen JI, Dillner J, Ursin G.

Int J Epidemiol. 2017 Apr 1;46(2):403-404g. doi: 10.1093/ije/dyw027. No abstract available.

PMID:
27063606

Supplemental Content

Loading ...
Support Center